ETFs
I
IGC
IGC Pharma Inc
0.3359
+0.0149+4.64%After Hours: 0.3288 -0.0071 -2.11%19:59 04/17 EDT
OPEN/PREV CLOSE0.3156/0.3190
TODAY RANGE0.3131-0.3283
VOL1.71M
MARKET CAP29.85M
52 WEEK RANGE0.2420-0.4985
AVG VOL (3M)965.01K
% TURNOVER1.84%
TURNOVER--
P/E (TTM)-4.0326
% RANGE4.76%
EPS(TTM)-0.0797
P/E(FORWARD)-4.0175
P/B4.115
BVPS0.0781
DIVIDEND--
P/S20.47
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP28.64M
SHARES OUTSTANDING92.87M
NEXT EARNINGS06/25-06/29
FREE FLOAT89.11M
LOT SIZE1
EX-DATE04/19/2013
News
Press Releases
Financial Reports
Profile
TipRanks·20h ago
IGC Pharma Secures New Promissory Note Financing Agreements
TipRanks·04/14 12:36
IGC Pharma reaches 80% enrollment in Phase 2 CALMA trial
Dow Jones·04/08 10:06
IGC Pharma Is Maintained at Buy by Ascendiant Capital
Dow Jones·04/08 10:06
IGC Pharma Price Target Raised to $5.25/Share From $5.00 by Ascendiant Capital
Benzinga·04/08 09:56
Ascendiant Capital Maintains Buy on IGC Pharma, Raises Price Target to $5.25
TipRanks·04/07 12:50
IGC announces activation of new clinical trial sate for Phase 2 CALMA trial
TipRanks·03/31 00:14
IGC Pharma Launches National Media Partnership to Boost Visibility
TipRanks·03/30 12:38
IGC Pharma enters national media partnership with New to The Street
TipRanks·03/25 12:20
IGC Pharma, New to The Street launch 12-part national media partnership
Seeking Alpha·03/19 19:02
IGC Pharma reports results
TipRanks·03/19 15:20
Congressman introduces bill for cannabis businesses to list on stock exchanges
Benzinga·03/19 14:30
'Medicare CBD Pilot Will Allow Some THC in Products'- Cannabis Wire
Same Industry
Name/Symbol
Change%
Price